Porvenir · Product for Pharmaceutical & Biotech Companies
High User Onboarding Drop-Off
for
Pharmaceutical & Biotech Companies.
Users sign up, then disappear before ever reaching real value.
Fixed for pharmaceutical & biotech companies. Pharmaceutical and biotech companies must build scientific credibility and investor confidence simultaneously.
Signs pharmaceutical & biotech companies recognise
Does this sound
familiar?
Why this hits pharmaceutical & biotech companies hardest
Sector-specific
pressure points.
Brand not communicating scientific rigour and clinical credibility to investors and KOLs
No digital strategy for building awareness with HCPs before a product launch
Website failing to explain complex mechanism-of-action in terms stakeholders understand
No content strategy building authority in a competitive therapeutic area
Our approach
How we fix it
for pharmaceutical & biotech companies.
Onboarding Funnel Audit
We analyse exactly where users drop off in the onboarding flow and why, using analytics and session recordings.
Redesign Toward the Aha Moment
We redesign onboarding to get users to the product's core value as fast as possible, cutting unnecessary steps.
Reduce Friction
We simplify forms, setup steps, and UI at each onboarding stage to remove unnecessary drop-off points.
Test & Iterate
We track activation rate before and after changes and keep iterating based on real user behaviour.
What pharmaceutical & biotech companies gain
Real outcomes.
A measurable improvement in activation and onboarding completion rate
Users reaching the product's core value faster
Improved trial-to-paid or signup-to-active conversion
FAQ
Common questions.
Do you specifically fix high user onboarding drop-off for pharmaceutical & biotech companies?
Yes. We understand the specific commercial context pharmaceutical & biotech companies operate in, and we apply that context directly to how we fix high user onboarding drop-off.
What causes high user onboarding drop-off for a pharmaceutical & biotech?
Too many steps or too much friction before users reach real value These issues tend to compound for pharmaceutical & biotech companies because of brand not communicating scientific rigour and clinical credibility to investors and kols.
How quickly can you fix high user onboarding drop-off for our pharmaceutical & biotech?
Most engagements addressing high user onboarding drop-off for pharmaceutical & biotech companies show measurable movement within 30–60 days, with the full fix delivered over 4–10 weeks depending on scope.
What results should a pharmaceutical & biotech expect?
A measurable improvement in activation and onboarding completion rate Users reaching the product's core value faster
Do you work with pharmaceutical & biotech companies outside our home market?
Yes - we work with pharmaceutical & biotech companies across North America, the UK, UAE, Europe, and Asia Pacific, delivered fully remotely.
Explore more
Related pages.
Other Problems We Solve for Pharmaceutical & Biotech Companies
- MVP Development for Pharmaceutical & Biotech Companies
- Mobile App Not Getting Downloads for Pharmaceutical & Biotech Companies
- Product Launch Underperformed for Pharmaceutical & Biotech Companies
- AI Features Not Adding Real Value for Pharmaceutical & Biotech Companies
- No Clear AI Strategy for Pharmaceutical & Biotech Companies
- App Store Rating and Reviews Declining for Pharmaceutical & Biotech Companies
High User Onboarding Drop-Off for Pharmaceutical & Biotech Companies
Ready to fix
this for your pharmaceutical & biotech?
Book a discovery call. No pitch, no pressure - just a focused conversation about where you are and where you want to be.